Generate a tailored SOP for Dr. Peter Gennemark. Improve your application with a focused, well-structured draft.
Peter Gennemark is an Adjunct Associate Professor at Linköping University, specializing in systems pharmacology with a focus on diabetes and cardiovascular disease treatment. He has extensive experience working in collaboration with the pharmaceutical industry, specifically as a principal scientist at AstraZeneca in Gothenburg, Sweden. His research aims to enhance the understanding of the biological mechanisms underlying diabetes and cardiovascular diseases, utilizing mathematical modeling techniques to explore disease progression and drug intervention. He has established noteworthy collaborations within the field, particularly with Gunnar Cedersund at the Institute of Medical Technology (IMT). Peter's work is directed towards integrating biological insights with pharmacological strategies to improve treatment outcomes.
AstraZeneca • Gothenburg, Sweden
Leading research in systems pharmacology and collaboration with academia.
Linköping University • Linköping, Sweden
Teaching and conducting research in medical technology with a focus on pharmacology.
Requirements are standardized across the Faculty of Science and Engineering (Institute of Technology) for international Master's programs.